opioid addiction Articles
-
Plethysmography for the assessment of opioid-induced respiratory depression
Opioid-related addiction, overdose and death is a widespread public health crisis. A recent paper published in The Journal of Pharmacology and Experimental Therapeutics by Dr. Renata Marchette working within the National Institute on Drug Abuse Intramural Research Program provides a model example of the how plethysmography can be used to assess ventilatory behavior changes that occur with opioid ...
-
Combatting the Opioid Crisis with Cell Therapies for Chronic Back Pain
It’s no secret that opioid addiction is at an all-time high and represents a major public health threat. The CDC estimates that opioid addiction resulted in a record 72,000 drug overdose deaths in 2017 alone. What strikes me as one of the most tragic parts of this narrative is that so many of these deaths were people who became addicted to opioids after simply seeking relief ...
-
Laser therapy offers pill-free foot pain relief
Sharon Whitt is settling in for a 10-minute treatment that she credits with getting the spring back in her step. “I like to dance, so that makes it a lot more comfortable to dance and not so much pain and pressure on the foot area,” she explains. Whitt was diagnosed with Morton’s Neuroma four years ago. It is a painful condition affecting nerves on the ball of the foot. ...
-
Temple research finds that tweaking CBD may help it curb pain and opioid use in mice
Doylestown-based Neuropathix is running safety tests required to start clinical trials in humans. The compound may help with neuropathy, a severe type of chronic pain associated with cancer treatment. The next generation of cannabis-inspired medicine might be grown in test tubes instead of greenhouses. Researchers at Temple University have partnered with Doylestown-based pharmaceutical company ...
-
CanaQuest Medical Corp (OTC: CANQF)
About: CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including ...
-
Philly Pharmacologists are Developing a Promising Pain-Relieving CBD Analog Drug
Scientists from Temple’s Lewis Katz School of Medicine and local biopharma company Neuropathix are testing their compound, KLS-13019, which is intended to target chemotherapy-induced pain in cancer patients. Sara Jane Ward, assistant professor of pharmacology at Temple University’s Lewis Katz School of Medicine, and Douglas Brenneman, chief pharmacologist at Neuropathix, discuss ...
-
CBD: Perils, Promise and Development for Neuropathic Pain
Cannabidiol, or CBD, is one of several compounds extracted from the cannabis (marijuana) plant. In recent years, CBD has become enormously popular, and its market is believed to be hundreds of millions of dollars. Believers and users of CBD extoll its benefits for inflammation, muscle soreness, pain, anxiety and a whole host of other things, including cancer. It is, however, very understudied. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you